Bradley Foster & Sargent Inc Sanofi Transaction History

Bradley Foster & Sargent Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 26, 2020	SELL	$49.47 - $53.77 $230,827 - $250,890	-4,666 Closed	0 $0
Q1 2020 May 07, 2020	SELL	$38.02 - $51.66 $17,641 - $23,970	-464 Reduced 9.04%	4,666 $204,000
Q4 2019 Jan 29, 2020	SELL	$44.25 - $50.86 $3,805 - $4,373	-86 Reduced 1.65%	5,130 $258,000
Q4 2018 Jan 30, 2019	SELL	$41.48 - $45.59 $2,488 - $2,735	-60 Reduced 1.14%	5,216 $226,000
Q3 2018 Oct 31, 2018	BUY	$40.0 - $44.84 $2,400 - $2,690	60 Added 1.15%	5,276 $236,000
Q1 2018 May 07, 2018	BUY	$38.98 - $45.76 $19,490 - $22,880	500 Added 10.6%	5,216 $209,000
Q3 2017 Nov 03, 2017	BUY	$47.04 - $50.34 $221,840 - $237,403	4,716	4,716 $235,000

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $123B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

Stay updated on Bradley Foster & Sargent Inc with notifications on news.